(Photo:
Artificial intelligence solution for quantitative knee osteoarthritis severity
assessment MediAI-OA, published in international journal_ⓒ Crescom Co., Ltd.)
Crescom (CEO Jae Joon Lee), a
company specializing in the artificial intelligence automatic analysis of
artificial intelligence medical images, announced that the verification results
of MediAI-OA, an artificial intelligence software for quantitatively assessing
the severity of knee osteoarthritis were published in the SCI-level
international academic journal BMS (BioMed Central) Musculoskeletal Disorders.
Knee osteoarthritis is a
disease that occurs due to degeneration in the knee joint area. In the case of
knee osteoarthritis, it is known that an accurate diagnosis in the early stages
is crucial in order to provide appropriate treatment and prevent irreversible
disabilities.
For an accurate diagnosis of
knee osteoarthritis, it is necessary to determine the severity using the
Kellgren-Lawrence (KL) grade, which is widely used worldwide for knee X-ray
imaging, and the KL grade is also used as a criterion for whether insurance
coverage for knee arthritis treatment in Korea is applied.
Crescom's MediAI-OA is a
newly developed artificial intelligence technology that automatically
quantifies the rate of joint space narrowing (JSN) and displays the reduction
rate as a percentage compared to the normal standard. Additionally, it also
detects and analyzes the presence of knee osteophytes. Integrating these
analyses, ultimately provides the KL grade of the target knee as a probability.
In this study, prominent
professors in the field of knee osteoarthritis in Korea have participated,
including Professor Chong-Bum Chang of the Department of Orthopedics at Seoul
National University Bundang Hospital, Professor Seung-Baik Kang at SMG-SNU
Boramae Medical Center, and Professor Chang-Ho Kang at Korea University Anam
Hospital. The study confirmed that MediAI-OA enables a more quantitative and
precise tracking of the progression of joint space narrowing. It provides
specialists with the JSN ratio, allowing them to monitor the progression of
joint space narrowing more accurately. Additionally, it includes the KL grade
and osteophytes of knee arthritis for a comprehensive assessment. It has been
confirmed to be useful in analyzing the characteristics of knee osteoarthritis
diagnosis.
Through these results, it is
expected that MediAI-OA will enable reliable evaluations of KL grades in the
medical field and reduce the burden of interpretation for specialists in radiology
and orthopedic.
MediAI-OA was built in the
insurance assessment system at the Health Insurance Review and Assessment
Service(HIRA) and is currently undergoing approval for manufacturing medical
devices by the Ministry of Food and Drug Safety(MFDS) with the aim of an
official launch in Korea early next year.
Crescom CEO Jae-Joon Lee
said, "We will continue to distribute specialized artificial intelligence
medical analysis solutions specializing in musculoskeletal diseases, such as
MediAI-OA, MediAI-BA for bone age solution, and MediAI-FX for fracture
detection solution, to clinical sites. Our goal is to help doctors provide
timely, prompt, and effective diagnosis and treatment anytime, anywhere."
And he also said, "We will work harder to provide accurate medical
analysis services."